NASDAQ : FHTX
Foghorn Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 124.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Foghorn Therapeutics Inc. (FHTX) reported revenue of 36.74M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 36.74M | 30.91M | 22.60M | 34.16M | 19.23M | 1.32M |
| Cost of Revenue | 78.83M | 85.47M | 94.53M | 109.69M | 105.62M | 80.33M |
| Gross Profit | -42.09M | -54.56M | -71.93M | -75.53M | -86.39M | -79.01M |
| Selling, General & Admin | 26.38M | 27.55M | 28.36M | 32.37M | 30.75M | 21.73M |
| Operating Expenses | 26.38M | 27.55M | 28.36M | 32.37M | 30.75M | 21.73M |
| Operating Income | -68.47M | -82.11M | -100.28M | -107.91M | -117.14M | -100.73M |
| Interest Expense | -1.91M | |||||
| Interest & Investment Income | 7.09M | 8.74M | 11.90M | 10.88M | 5.67M | 59.00K |
| Other Non Operating Income (Expenses) | 1.08M | 3.36M | 4.16M | 2.83M | 2.58M | 2.49M |
| EBT Excluding Unusual Items | -60.30M | -70.00M | -84.22M | -94.20M | -108.88M | -100.09M |
| Asset Writedown | -5.91M | -5.91M | -2.40M | |||
| Other Unusual Items | 1.63M | 1.63M | -1.23M | |||
| Pretax Income | -64.58M | -74.28M | -86.62M | -94.20M | -108.88M | -101.32M |
| Income Tax Expense | 4.23M | |||||
| Net Income | -64.58M | -74.28M | -86.62M | -98.43M | -108.88M | -101.32M |
| Net Income to Common | -64.58M | -74.28M | -86.62M | -98.43M | -108.88M | -101.32M |
| Shares Outstanding (Basic) | 66.57M | 62.98M | 54.90M | 41.97M | 41.59M | 37.17M |
| Shares Outstanding (Diluted) | 66.57M | 62.98M | 54.90M | 41.97M | 41.59M | 37.17M |
| EPS (Basic) | -0.97 | -1.18 | -1.58 | -2.34 | -2.62 | -2.73 |
| EPS (Diluted) | -0.97 | -1.18 | -1.58 | -2.34 | -2.62 | -2.73 |
| Free Cash Flow | -84.29M | -86.15M | -101.31M | -119.33M | 192.40M | -53.56M |
| Free Cash Flow Per Share | -1.27 | -1.37 | -1.84 | -2.84 | 4.63 | -1.44 |
| Gross Margin | -114.57% | -176.51% | -221.15% | |||
| Operating Margin | -186.38% | -265.64% | -443.70% | -315.93% | -609.20% | -7,637.15% |
| Profit Margin | -175.78% | -240.33% | -383.24% | -288.17% | -566.27% | -7,681.58% |
| Free Cash Flow Margin | -229.43% | -278.72% | -448.24% | -349.38% | 1,000.63% | -4,060.88% |
| EBITDA | -66.35M | -78.78M | -97.17M | -104.45M | -113.82M | -97.51M |
| EBITDA Margin | -180.61% | -254.86% | ||||
| D&A For EBITDA | 2.12M | 3.33M | 3.12M | 3.45M | 3.32M | 3.23M |
| EBIT | -68.47M | -82.11M | -100.28M | -107.91M | -117.14M | -100.73M |
| EBIT Margin | -186.38% | -265.64% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 68.08M | 80.88M | 55.45M | 80.34M | 52.21M | 101.14M |
| Short-Term Investments | 99.50M | 78.02M | 188.29M | 153.72M | 293.58M | 53.15M |
| Cash & Short-Term Investments | 167.58M | 158.89M | 243.75M | 234.06M | 345.80M | 154.29M |
| Receivables | 300.00M | |||||
| Prepaid Expenses | 2.46M | 3.09M | 5.85M | 6.12M | 5.60M | 5.27M |
| Restricted Cash | 1.25M | |||||
| Total Current Assets | 170.05M | 163.24M | 249.60M | 240.18M | 351.40M | 459.56M |
| Property, Plant & Equipment | 31.34M | 32.86M | 32.60M | 42.91M | 49.40M | 56.08M |
| Other Long-Term Assets | 2.00M | 2.00M | 1.78M | 2.82M | 4.09M | 4.13M |
| Total Assets | 203.39M | 198.10M | 283.98M | 285.92M | 404.88M | 519.77M |
| Accounts Payable | 3.21M | 4.27M | 3.79M | 6.26M | 5.41M | 3.82M |
| Accrued Expenses | 7.96M | 11.36M | 8.53M | 8.43M | 11.00M | 9.56M |
| Current Portion of Leases | 2.82M | 923.00K | 9.07M | 8.52M | 5.97M | 6.99M |
| Current Income Taxes Payable | 674.00K | |||||
| Current Unearned Revenue | 36.59M | 43.19M | 45.61M | 34.55M | 32.82M | 28.32M |
| Total Current Liabilities | 50.58M | 59.74M | 66.99M | 58.44M | 55.20M | 48.69M |
| Long-Term Leases | 40.28M | 40.35M | 28.06M | 36.55M | 45.54M | 51.34M |
| Long-Term Unearned Revenue | 193.22M | 205.96M | 234.46M | 268.12M | 304.00M | 322.73M |
| Other Long-Term Liabilities | 350.00K | 556.00K | 29.00K | 143.00K | ||
| Total Liabilities | 284.43M | 306.60M | 329.51M | 363.11M | 404.77M | 422.90M |
| Common Stock | 6.00K | 6.00K | 6.00K | 4.00K | 4.00K | 4.00K |
| Additional Paid-In Capital | 578.62M | 523.94M | 512.51M | 395.20M | 377.23M | 361.13M |
| Retained Earnings | -659.53M | -632.47M | -558.18M | -471.56M | -373.14M | -264.26M |
| Comprehensive Income & Other | -134.00K | 24.00K | 135.00K | -826.00K | -3.99M | -10.00K |
| Total Common Equity | -81.04M | -108.50M | -45.53M | -77.19M | 112.00K | 96.87M |
| Shareholders' Equity | -81.04M | -108.50M | -45.53M | -77.19M | 112.00K | 96.87M |
| Total Liabilities & Equity | 203.39M | 198.10M | 283.98M | 285.92M | 404.88M | 519.77M |
| Total Debt | 43.10M | 41.27M | 37.13M | 45.07M | 51.51M | 58.33M |
| Net Cash (Debt) | 124.48M | 117.62M | 206.62M | 188.98M | 294.29M | 95.96M |
| Net Cash Per Share | 1.87 | 1.87 | 3.76 | 4.50 | 7.08 | 2.58 |
| Filing Date Shares Outstanding | 59.39M | 58.70M | 55.61M | 42.57M | 41.80M | 41.42M |
| Total Common Shares Outstanding | 58.71M | 56.66M | 55.59M | 42.28M | 41.80M | 41.30M |
| Working Capital | 119.47M | 103.50M | 182.61M | 181.75M | 296.19M | 410.87M |
| Book Value Per Share | -1.38 | -1.92 | -0.82 | -1.83 | 0.00 | 2.35 |
| Tangible Book Value | -81.04M | -108.50M | -45.53M | -77.19M | 112.00K | 96.87M |
| Tangible Book Value Per Share | -1.38 | -1.92 | -0.82 | -1.83 | 0.00 | 2.35 |
| Machinery | 8.97M | 8.92M | 8.03M | 7.73M | 6.80M | 5.80M |
| Leasehold Improvements | 17.02M | 17.24M | 17.12M | 17.06M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -64.58M | -74.28M | -86.62M | -98.43M | -108.88M | -101.32M |
| Depreciation & Amortization | 2.12M | 3.33M | 3.12M | 3.45M | 3.32M | 3.23M |
| Loss (Gain) From Sale of Assets | 31.00K | 31.00K | 3.00K | 6.00K | ||
| Asset Writedown & Restructuring Costs | 5.91M | 5.91M | 2.40M | |||
| Loss (Gain) From Sale of Investments | -1.67M | -1.93M | -4.61M | -2.65M | -1.29M | 179.00K |
| Stock-Based Compensation | 9.91M | 10.40M | 11.89M | 16.19M | 14.34M | 8.38M |
| Other Operating Activities | 709.00K | 2.57M | 5.68M | 5.21M | 4.58M | 5.84M |
| Change in Accounts Receivable | 300.00M | -300.00M | ||||
| Change in Accounts Payable | -115.00K | 481.00K | -2.48M | 846.00K | 1.61M | 135.00K |
| Change in Unearned Revenue | -36.74M | -30.91M | -22.60M | -34.16M | -14.23M | 336.48M |
| Change in Other Net Operating Assets | 177.00K | -1.71M | -7.19M | -8.57M | -5.84M | -3.17M |
| Operating Cash Flow | -84.24M | -86.10M | -100.41M | -118.11M | 193.61M | -50.25M |
| Capital Expenditures | -50.00K | -50.00K | -906.00K | -1.22M | -1.21M | -3.31M |
| Investment in Securities | 28.17M | 112.09M | -29.00M | 145.67M | -243.11M | 39.49M |
| Investing Cash Flow | 28.12M | 112.04M | -29.90M | 144.45M | -244.32M | 36.17M |
| Long-Term Debt Repaid | -21.20M | |||||
| Net Debt Issued (Repaid) | -21.20M | |||||
| Issuance of Common Stock | 50.73M | 1.02M | 106.01M | 1.78M | 1.76M | 43.62M |
| Other Financing Activities | -347.00K | -585.00K | ||||
| Financing Cash Flow | 50.38M | 1.02M | 105.43M | 1.78M | 1.76M | 22.42M |
| Net Cash Flow | -5.74M | 26.96M | -24.88M | 28.12M | -48.95M | 8.34M |
| Free Cash Flow | -84.29M | -86.15M | -101.31M | -119.33M | 192.40M | -53.56M |
| Free Cash Flow Margin | -229.43% | -278.72% | -448.24% | -349.38% | 1,000.63% | -4,060.88% |
| Free Cash Flow Per Share | -1.27 | -1.37 | -1.84 | -2.84 | 4.63 | -1.44 |
| Levered Free Cash Flow | -51.95M | -35.23M | -40.30M | -48.87M | 250.45M | -329.38M |
| Unlevered Free Cash Flow | -51.95M | -35.23M | -40.30M | -48.87M | 250.45M | -328.18M |
| Cash Interest Paid | 1.72M | |||||
| Cash Income Tax Paid | 3.00K | 9.00K | 860.00K | 3.55M | ||
| Change in Working Capital | -36.68M | -32.14M | -32.27M | -41.88M | 281.55M | 33.44M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 126.49M | 305.38M | 262.40M | 272.30M | 266.70M | 848.32M |
| Enterprise Value | 2.01M | 147.63M | 34.07M | 59.49M | -53.63M | 807.40M |
| Last Close Price | 2.13 | 5.40 | 4.72 | 6.45 | 6.38 | 22.87 |
| PS Ratio | 3.44 | 9.88 | 11.61 | 7.97 | 13.87 | 643.15 |
| PB Ratio | -2.81 | -5.76 | -3.53 | 2,381.22 | 8.76 | |
| P/TBV Ratio | 2,381.22 | 8.76 | ||||
| P/FCF Ratio | 1.39 | |||||
| P/OCF Ratio | 1.38 | |||||
| EV/Sales Ratio | 0.05 | 4.78 | 1.51 | 1.74 | 612.13 | |
| Debt / Equity Ratio | -0.53 | -0.38 | -0.82 | -0.58 | 459.88 | 0.60 |
| Debt / FCF Ratio | 0.27 | |||||
| Net Debt / Equity Ratio | 1.54 | 1.08 | 4.54 | 2.45 | -2,627.60 | -0.99 |
| Net Debt / EBITDA Ratio | 1.88 | 1.49 | 2.13 | 1.81 | 2.59 | 0.98 |
| Net Debt / FCF Ratio | 1.48 | 1.36 | 2.04 | 1.58 | -1.53 | 1.79 |
| Asset Turnover | 0.17 | 0.13 | 0.08 | 0.10 | 0.04 | 0.00 |
| Quick Ratio | 3.31 | 2.66 | 3.64 | 4.00 | 6.26 | 9.33 |
| Current Ratio | 3.36 | 2.73 | 3.73 | 4.11 | 6.37 | 9.44 |
| Return on Equity (ROE) | -224.54% | -83.37% | ||||
| Return on Assets (ROA) | -19.92% | -21.29% | -22.00% | -19.53% | -15.83% | -16.24% |
| Return on Capital Employed (ROCE) | -44.80% | -59.30% | -46.20% | -47.40% | -33.50% | -21.40% |
| Earnings Yield | -45.55% | -24.32% | -33.01% | -36.15% | -40.83% | -11.94% |
| FCF Yield | -66.64% | -28.21% | -38.61% | -43.82% | 72.14% | -6.31% |
| Buyback Yield / Dilution | -5.91% | -14.72% | -30.79% | -0.92% | -11.89% | -236.49% |